{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:08Z","timestamp":1791489668462,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T00:00:00Z","timestamp":1752969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016148","name":"Korean Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016148","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016147","name":"Korean Association for the Study of the Liver","doi-asserted-by":"publisher","award":["KASLKLF 2024-06"],"award-info":[{"award-number":["KASLKLF 2024-06"]}],"id":[{"id":"10.13039\/501100016147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jhepr.2025.101524","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T23:29:26Z","timestamp":1753399766000},"page":"101524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence and risk factors of hepatocellular carcinoma in patients with autoimmune hepatitis in Asia"],"prefix":"10.1016","volume":"7","author":[{"given":"Jiwon","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7346-5974","authenticated-orcid":false,"given":"Sun Young","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunhee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7470-5850","authenticated-orcid":false,"given":"Jonggi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jhepr.2025.101524_bib1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.15217","volume":"42","author":"Lohse","year":"2022","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101524_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"Autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101524_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","article-title":"Update of the simplified criteria for autoimmune hepatitis: evaluation of the methodology for immunoserological testing","volume":"74","author":"Galaski","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101524_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cld.1080","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: a patient-friendly summary of the 2019 AASLD guidelines","volume":"17","author":"Volk M","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101524_bib5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3350\/cmh.2023.0087","article-title":"KASL clinical practice guidelines for management of autoimmune hepatitis 2022","volume":"29","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101524_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2020.03.015","article-title":"Autoimmune hepatitis: possible triggers, potential treatments","volume":"73","author":"Herkel","year":"2020","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101524_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gr\u00f8nb\u00e6k","year":"2014","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101524_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13023-024-03086-0","article-title":"Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database","volume":"19","author":"Lim","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhepr.2025.101524_bib9","first-page":"65doi","article-title":"Global incidence and prevalence of autoimmune hepatitis, 1970\u20132022: a systematic review and meta-analysis","author":"Hahn","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101524_bib10","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","article-title":"Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis","volume":"15","author":"Tansel","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101524_bib11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101524_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101524_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14309\/ajg.0000000000001525","article-title":"Increased cancer risk in autoimmune hepatitis: a Danish nationwide cohort study","volume":"117","author":"Jensen","year":"2022","journal-title":"Official J Am Coll Gastroenterol ACG"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101524_bib14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/aje\/kwab119","article-title":"Cancer risk in patients with autoimmune hepatitis: a nationwide population-based cohort study with histopathology","volume":"191","author":"Sharma","year":"2022","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101524_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2023.09.010","article-title":"Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"80","author":"Colapietro","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101524_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11901-018-0399-5","article-title":"Ethnic and racial differences in autoimmune liver diseases","volume":"17","author":"Freire","year":"2018","journal-title":"Curr Hepatol Rep"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101524_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/gut.50.5.713","article-title":"Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin","volume":"50","author":"Zolfino","year":"2002","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101524_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182391","article-title":"Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101524_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3350\/cmh.2019.0010n","article-title":"KASL clinical practice guidelines for liver cirrhosis: varices, hepatic encephalopathy, and related complications","volume":"26","year":"2020","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101524_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group","volume":"76","author":"Pape","year":"2022","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101524_bib21","article-title":"External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort","volume":"6","author":"Grossar","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101524_bib22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"13","key":"10.1016\/j.jhepr.2025.101524_bib23","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/cncr.31406","article-title":"Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: a prospective cohort study in Korea","volume":"124","author":"Yi","year":"2018","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101524_bib24","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/jgh.12952","article-title":"Autoimmune hepatitis: east meets west","volume":"30","author":"Yang","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101524_bib25","doi-asserted-by":"crossref","unstructured":"Pasta A, Pieri G, Plaz Torres MC, et al. Hepatocellular carcinoma in patients with autoimmune hepatitis. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2024.03.025.","DOI":"10.1016\/j.jhep.2024.03.025"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101524_bib26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","article-title":"Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening","volume":"48","author":"Yeoman","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101524_bib27","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s10620-018-5441-5","article-title":"Older age and disease duration are highly associated with hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"64","author":"Dakhoul","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101524_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7570\/jomes23031","article-title":"Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean society for the study of obesity","volume":"32","author":"Haam","year":"2023","journal-title":"J Obes Metab Syndr"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101524_bib29","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/HEP.0000000000000589","article-title":"Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry","volume":"79","author":"Slooter","year":"2024","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101524_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5217\/ir.2023.00133","article-title":"Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease","volume":"21","author":"Kim","year":"2023","journal-title":"Intest Res"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925002034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925002034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T23:27:27Z","timestamp":1759879647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925002034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2589555925002034"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101524","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and risk factors of hepatocellular carcinoma in patients with autoimmune hepatitis in Asia","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101524"}}